Epilepsy Research
Volume 27, Issue 3 , Pages 195-204 , June 1997

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy1

  • Pierre Alfred Bill

      Affiliations

    • Department of Neurology, Wentworth Hospital, Durban, South Africa
    • ,
  • Ulf Vigonius

      Affiliations

    • Novartis Sverige AB, Västra Frölunda, P.O. Box 1150, S-18311 Taeby, Sweden
    • Corresponding Author InformationCorresponding author.
    • ,
  • Harald Pohlmann

      Affiliations

    • Novartis Pharma AG, Basel, Switzerland
    • ,
  • Carlos Alberto M Guerreiro

      Affiliations

    • Department of Neurology, University of Campinas, UNICAMP, Campinas, Brazil
    • ,
  • Silvia Kochen

      Affiliations

    • Centre of Epilepsy, Division of Neurology, UBA, Hospital Ramos Mejia, Buenos Aires, Argentina
    • ,
  • David Saffer

      Affiliations

    • Department of Neurology, Baragwanath Hospital, Johannesburg, South Africa
    • ,
  • Alan Moore

      Affiliations

    • Novartis Pharma AG, Basel, Switzerland

Received 26 March 1997 ,Revised 11 April 1997 ,Accepted 13 April 1997.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-1211(97)00024-7

Epilepsy Research
Volume 27, Issue 3 , Pages 195-204 , June 1997

Article Tools

* Image Usage & Resolution